- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 347
UBiqube nets NTT Comware on way to $20m
NTT Comware has agreed to take part in a series B round the corporate-backed orchestration software producer intends to close at $20m.
Apr 10, 2019InMotion heads to The Out
Jaguar Land Rover's corporate VC unit has diversified from its external investments to launch a car rental service in London called The Out.
Apr 10, 2019Avectas collects $10m
NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.
Apr 10, 2019Monzo to put $130m on its books
The deal will double the Orange and Stripe-backed digital bank’s valuation to $2.6bn, making it the second most valuable fintech developer in the UK.
Apr 10, 2019Fliit fits in series A funding
AP Moller – Maersk took part in an $11.2m round that will accelerate the international expansion of the food logistics marketplace.
Apr 10, 2019Theya settles into $750,000
NovaUCD-based patient lingerie manufacturer Theya Healthcare has been backed by investors including Enterprise Ireland as it prepares for expansion in the US.
Apr 9, 2019Reeve takes chair at Albion Capital
Patrick Reeve, managing partner at Albion Capital, which manages UCL Technology Fund, has passed his position onto his deputy to become the firm’s first chairman.
Apr 9, 2019Liopa gets more than lip service in seed round
Queen’s University Belfast speech recognition technology spinout Liopa is working on a product that analyses lip movements to provide more robust analysis in noisy environments.
Apr 8, 2019Property Finder locates Zingat for another investment
Property Finder has increased its stake in online property listings platform Zingat from nearly 17% to 37% with an investment of about $12m.
Apr 8, 2019Boehringer Ingelheim regenerates Agomab
Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer that was co-led by V-Bio Ventures and Advent France Biotechnology.
Apr 8, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


